- Home
- ICUCW vs BRKRP Comparison
ICUCW vs BRKRP Comparison
Compare ICUCW & BRKRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICUCW | BRKRP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 17 | 11085 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICUCW | BRKRP |
|---|---|---|
| Price | $0.02 | $433.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 56.8K | 3.4K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $256.35 |
| 52 Week High | $0.08 | $435.45 |
Technical Indicators
Market Signals| Indicator | ICUCW | BRKRP |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 74.89 |
| Support Level | $0.01 | $365.07 |
| Resistance Level | $0.04 | N/A |
| Average True Range (ATR) | 0.00 | 5.36 |
| MACD | 0.00 | 9.56 |
| Stochastic Oscillator | 68.89 | 87.59 |
Price Performance
Historical ComparisonAbout ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.